Biotech

News

US immunology biotech Zenas BioPharma files $100m IPO

Just a few months after raising $200 million in third-round financing, immunology specialist Zenas BioPharma has filed an initial public offering in the US seeking to add another $100 milli

News

Versant, Novartis team up again in hunt for another Chinook

Novartis and venture capital firm Versant have set up a new biotech – Borealis Biosciences – using a similar model to their earlier alliance to create Chinook Therapeutics.

News

Buoyed by muscular dystrophy data, Avidity raises $345m

Just a few weeks after Avidity Biosciences made a stir with new data on its experimental therapy for Duchenne muscular dystrophy, the biotech has closed a public offering that raised an imp

News

BiVictriX's chief executive Tiffany Thorn

Another AIM defection as BiVictriX plans to delist

The list of UK biotechs deciding to abandon listings on the AIM exchange in the UK just lengthened, after BiVictriX said it wants to cancel its shares and go private.

News

Biopharma, finance vets launch $600m life sciences loan firm

There's a new source of funding for life sciences companies in town, providing credit as an alternative to other financing avenues such as venture capital.

News

FibroGen scientist records data manually into a notebook

FibroGen wields axe as pancreatic cancer drug is canned

FibroGen has pulled the plug on its lead drug pamrevlumab after two failed trials in pancreatic cancer and immediately announced plans to shed three-quarters of its workforce.

US immunology biotech Zenas BioPharma files $100m IPO

Versant, Novartis team up again in hunt for another Chinook

Buoyed by muscular dystrophy data, Avidity raises $345m

Another AIM defection as BiVictriX plans to delist

Biopharma, finance vets launch $600m life sciences loan firm

FibroGen wields axe as pancreatic cancer drug is canned

Lilly bags FDA okay for Wegovy pill rival orforglipron

Using AI-driven synthetic personas to take your insights fur...

Biotech

Editor's Picks